Liver transplantation (LT) is considered the best curative treatment for patients with cirrhosis and hepatocellular carcinoma (HCC) within Milan criteria. Several therapeutic procedures have been proposed as bridging treatments for individuals with HCC awaiting LT.
For individuals with severe lung disease, a lung transplant is an effective treatment. New advances in lung transplant technology have extended the life of a lung once it has been removed from the donor’s body.
Autoimmune diseases are caused by an overactive immune system that targets the patient’s own cells. Most individuals with autoimmune disorders respond to conventional drug therapies; however, conventional drug therapies are not curative.
Allocation of liver donor organs in the United States is a complex and evolving process. New allocation/distribution systems are in development that attempt to more accurately allocate organs.
Facebook
X
LinkedIn
Forward
